In human colon cancer samples, a significant correlation between PPARγ and the expression of pRb, cyclin D1, p16, and p21 was found; however, surprisingly, PPARγ expression did not correlate with the stage, grade of differentiation, metastasis, tumor proliferative capacity, or patient survival [374]. Here, CDKN2A is linked to neoplasm.